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Abstract
Background: We report a case of a patient with appendicular bone involvement of diffuse large B-cell lymphoma
visualized by whole-body technetium-99m methylenediphosphonate bone scintigraphy (bone scan) and 18F-
fluorodeoxyglucose positron emission tomography/computed tomography.
Case presentation: A 73-year-old Asian man who had gingival swelling of the labial area of the left maxillary
lateral incisor presented to our institution. Positron emission tomography/computed tomography demonstrated
hypermetabolic lesions with maximum standardized uptake values of 12.15 in the left testis, 1.92 in the skin of the
right chest, and 2.88 in the left ulna and third metatarsal bone. A bone scan showed multiple uptakes in the left
ulna, hand, both tibiae, and the left foot. We diagnosed the tumor as diffuse large B-cell lymphoma by excision.
Magnetic resonance imaging showed enhanced signaling of lesions with soft tissue edema in the olecranon of the
left ulna, the third metacarpal bone of the left hand, and the third metatarsal bone of the left foot. Magnetic
resonance imaging findings prompted a diagnosis of lymphoma. Eight cycles of chemotherapy plus external
radiotherapy targeted to the involved bone sites were given for 5 months. Follow-up positron emission
tomography/computed tomography and bone scanning revealed the disappearance of hypermetabolism and
decreased uptake in lesions compared with the previous images. Laboratory data were also all within the normal
limits after chemotherapy.
Conclusions: This report highlights that appendicular bone involvement of diffuse large B-cell lymphoma can be
detected on whole-body bone scans and by positron emission tomography/computed tomography.
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Background
Malignant lymphoma of bone accounts for 7% of all
bone malignancies and 5% of extranodal lymphomas [1].
Reported bone involvement of diffuse large B-cell
lymphoma (DLBL) is in the femur (27%), pelvis (15%),
tibia/fibula (13%), polyostotic (13%), humerus (12%),
spine (9%), other (5%), mandible (2%), radius/ulna (1%),
scapula (1%), and skull (1%). Uncommonly, bones of the
hands and feet are involved [2].
Technetium-99m methylenediphosphonate bone scin-
tigraphy (bone scan) is a cost-effective and useful tool in
a variety of diseases, and it is the most commonly used
means of detecting bone metastasis, with variable diag-
nostic sensitivity and comparatively low specificity [3].
18F-fluorodeoxyglucose ([18F]-FDG) positron emission
tomography/computed tomography (PET/CT) is a
standard diagnostic modality in the workup of many ma-
lignancies. Because malignant cells exhibit increased
proliferation and glucose metabolism, PET/CT scans
noninvasively detect a primary lesion and cancer metas-
tasis in images by increased [18F]-FDG uptake [4]. This
case report describes the detection of appendicular bone
involvement of DLBL on whole-body bone scans and
PET/CT scans.
Case presentation
A 73-year-old Asian man who had gingival swelling of
the labial area of the left maxillary lateral incisor pre-
sented to our institution. Initially, it was suspected of
being a radicular cyst in the left maxillary sinus incisor.
No other symptoms, including fever, cough, or dyspnea,
were present. The patient had no family history of
cancer. Laboratory data, including tumor markers and
peripheral blood appearance, were all within the normal
limits. The patient underwent excision of the swelling. A
pathological examination revealed a highly pleomorphic
large-cell proliferation. Immunohistochemistry was dif-
fusely positive for cluster of differentiation (CD) 20 and
B-cell lymphoma 6 proteins. The patient’s Ki-67 index
was approximately 80%. His tumor cells were negative
for CD3, CD10, and creatine kinase. We diagnosed the
tumor as DLBL with an immunohistological staining
pattern consistent with germinal center B-cell derivation.
PET/CT was performed to determine the stage.
Increased FDG uptake in multiple masses and nodular
lesions was evident, with maximum standardized uptake
values of 12.15 in the left testis, 1.92 in the skin of the
right chest, and 2.88 in the left ulna and the third meta-
tarsal bone (Fig. 1a and b). A bone scan performed to
diagnose the bone lesions revealed multiple uptakes in
the left ulna, hand, both tibiae, and the left foot (Fig. 2a).
On the basis of the PET/CT result, left orchiectomy was
performed for accurate histological diagnosis. The lesion
was confirmed as DLBL. Axial and sagittal T2-weighted
magnetic resonance imaging (MRI) showed enhanced
signaling of lesions with soft tissue edema in the olecra-
non of the left ulna (Fig. 3a), the third metacarpal bone
of the left hand (Fig. 3b), and the third metatarsal bone
Fig. 1 Images of a 73-year-old Asian man who underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography for
metastasis evaluation for malignant lymphoma. a and b Maximum-intensity projection images obtained by 18F-fluorodeoxyglucose positron
emission tomography/computed tomography shows focal hypermetabolic lesions (maximum standardized uptake values 1.92 [chest wall], 2.56
[olecranon of left ulna], 2.88 [left third metacarpal bone], and 12.15 [left testis]; red arrows), which were proven to be malignant lymphoma by
histological and radiological examinations. c Follow-up 18F-fluorodeoxyglucose positron emission tomography/computed tomography after
chemotherapy shows disappeared hypermetabolic lesions in the above-described sites
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of the left foot (Fig. 3c). MRI findings prompted a diag-
nosis of lymphoma. Eight cycles chemotherapy were
given according to the rituximab, cyclophosphamide,
doxorubicin, vincristine, and prednisone protocol plus
external radiotherapy targeted to the involved bone sites
for 5 months. Follow-up PET/CT (Fig. 1c) and bone
scan (Fig. 2b) revealed the disappearance of hypermetab-
olism and decreased uptake in lesions compared with
the previous images. Laboratory data were also all within
the normal limits after chemotherapy.
Discussion
DLBL comprises a group of large, lymphoid B-cell
malignant proliferations that is clinically, morphologic-
ally, and genetically heterogeneous. It constitutes about
30% of all non-Hodgkin lymphomas and is the most
common histologic subtype [5]. It is also characterized
by relatively frequent extranodal presentation. The most
common extranodal localizations are the stomach, cen-
tral nerve system, bone, testis, and liver [6]. Presently,
only extranodal areas affecting gingival areas of the left
maxillary lateral incisor, the chest wall, the testis, and
distal appendicular bone were affected with DLBL.
Bone scan is widely available and commonly used to
detect bone metastases from cancers because it is inex-
pensive and sensitive and is able to capture a whole-body
image [7]. Notably, PET/CT also provides whole-body
images with an overall assessment of disease extent, and
so can reveal lesions that are hidden on other conven-
tional images. PET/CT has several advantages in the man-
agement of patients with lymphoma during staging and
follow-up [8]. In our patient, DLBL was first diagnosed in
the gingival area of the left maxillary lateral incisor, but
unrevealed lymphoma involvement on the chest wall,
testis, and distal appendicular bone were subsequently
detected by whole-body bone scanning and PET/CT.
PET/CT also is important in the early prediction of re-
sponse to chemotherapy and the evaluation of residual
masses after chemotherapy or radiation therapy [9, 10]. In
our patient, decreased uptake visualized by bone scanning
and PET/CT was apparent after chemo- and radiotherapy.
Malignant lymphoma of bone is classified into four
subtypes: primary bone lymphoma (PBL), multifocal
PBL, and disseminated lymphoma with secondary osse-
ous involvement either within 6 months of lymphoma
diagnosis via soft tissue/nodal disease or more than 6
months after diagnosis [11]. PBL is defined as lymphoma
that is confined to the bone or bone marrow without
evidence of concurrent systemic involvement, and it has
the best prognosis of all primary bone malignant lesions
[12]. PBL is commonly found in the appendicular
skeleton, typically affecting the metadiaphysis of the
femur, tibia, and humerus, and it has a better prognosis
than disseminated disease with secondary osseous in-
volvement [11]. Secondary osseous lymphoma is usually
due to DLBL [11, 13] and preferentially affects the axial
skeleton, such as the spine, pelvis, skull, ribs, and facial
bones [13]. Secondary osseous lymphoma of distal
appendicular bone is extremely rare. In our patient,
DLBL was detected in the gingival area, but multiple
lymphomatous involvement on the chest wall, testis, and
distal appendicular bone was detected by bone scanning
and PET/CT. Despite the improvement of disease by
chemo- and radiotherapy, a poor prognosis is expected.
Fig. 2 a Technetium-99m bone scintigraphy shows increased uptake in the olecranon of the left ulna, as well as the left hand and foot (red arrows). b
Follow-up technetium-99m bone scintigraphy after chemoradiotherapy shows decreased uptake in the third metacarpal bone of the left hand (red arrow)
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Conclusions
Secondary DLBL involvement of distal appendicular
bone is extremely rare. Bone scanning and PET/CT are
important in the diagnosis and response assessment of
DLBL involvement of appendicular bone, as in our pa-
tient. Bone scanning and PET/CT may be instrumental
in establishing a diagnosis of lymphomatous involvement
of distal appendicular bone.
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Fig. 3 a Axial and sagittal T2-weighted magnetic resonance images show an increased signal mass in the olecranon of the left ulna (red arrow). b Axial
and sagittal T2-weighted magnetic resonance images show an increased signal mass in the third metacarpal bone of the left hand (red arrow). c Axial
and coronal T2-weighted magnetic resonance images show an increased signal mass in the third metatarsal bone of the left foot (red arrow)
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